Abstract: The present invention provides microfluidic technology enabling rapid and economical manipulation of reactions on the femtoliter to microliter scale.
Type:
Application
Filed:
February 19, 2014
Publication date:
July 24, 2014
Applicant:
The University of Chicago
Inventors:
Rustem F. Ismagilov, Bo Zheng, Cory John Gerdts
Abstract: Embodiments of content addressable memories for internet protocol devices and operations are described herein. Other examples and related methods are also disclosed herein.
Type:
Application
Filed:
March 19, 2014
Publication date:
July 24, 2014
Applicant:
Arizona Board of Regents for and on Behalf of Arizona State University
Inventors:
Satendra Kumar Maurya, Lawrence T. Clark
Abstract: In an apparatus for providing a multimedia streaming service, a server transmits a Media Presentation Description (MPD) including information about media data to a client, receives a partial request message requesting a part of media data having a range according to a defined range in the MPD, and transmits to the client a segment having the range in response to the partial request message. The segment includes at least one fragment, segment index information indicating the position of the at least one fragment in the segment, and fragment index information including information indicating the position of each of a plurality of samples included in the at least one fragment and information about a total size of the samples.
Type:
Application
Filed:
March 19, 2014
Publication date:
July 24, 2014
Applicants:
University-Industry Cooperation Group of Kyung Hee University, Samsung Electronics Co., Ltd.
Inventors:
Kyung-Mo PARK, Doug-Young SUH, Yong-Hun LEE, Jae-Yeon SONG
Abstract: A method for modifying a surface of a powder is provided. The method includes steps of providing a polar aprotic solvent; and mixing the polar aprotic solvent with the powder so that the polar aprotic solvent adheres to the surface of the powder.
Type:
Application
Filed:
July 18, 2013
Publication date:
July 24, 2014
Applicant:
National Taiwan University of Science and Technology
Inventors:
Bing Joe Hwang, Li-Chyong Chen, Kuei-Hsien Chen, Deniz Po Wong, Han-Ping Tseng
Abstract: Provided is a cassette for deleting a target gene comprising (a) a promoter-specific homologous region having a sequence identity to a portion of a promoter region of the target gene, wherein the degree of sequence identity is sufficient to drive homologous recombination therebetween, (b) a marker gene operably linked to the promoter-specific homologous region, and (c) a gene-specific homologous region adjacent to 3?-end of the marker gene and having a sequence identity to at least a portion of the target gene, wherein the degree of sequence identity is sufficient to drive homologous recombination therebetween.
Type:
Application
Filed:
January 21, 2014
Publication date:
July 24, 2014
Applicants:
Chung-Ang University Industry Cooperation Foundation, Samsung Electronics Co., Ltd.
Inventors:
JAE-YOUNG KIM, JIN-KYU KANG, CHANG-DUK KANG, SUNG-SOO KIM, JU-YOUNG LEE, HYUN-AH KANG, JAE-CHAN PARK, HUI-SUB LIM, JIN-HO CHOO
Abstract: Diagnostic methods relating to a cardiac ventricular dysfunction are provided. In some embodiments, the diagnostic method is a method of diagnosing diastolic dysfunction in the absence of systolic dysfunction in a subject. The method comprises assaying a sample obtained from the subject for evidence of activation of renin-angiontensin system (RAS), evidence of oxidative stress, a level of adiponectin, or a combination thereof, wherein, when there is a lack of evidence of RAS activation, a lack of evidence of oxidative stress, a reduction in the level of adiponectin, or a combination thereof, as compared to a control subject, the subject is diagnosed with diastolic dysfunction in the absence of systolic dysfunction. Also provided are methods of diagnosing a type of cardiac ventricular dysfunction, methods of determining a therapeutic regimen for a subject suffering from a cardiac ventricular dysfunction, and methods of treating diastolic dysfunction in the absence of systolic dysfunction.
Type:
Application
Filed:
August 20, 2013
Publication date:
July 24, 2014
Applicant:
The Board of Trustrees of The University of Illinois
Abstract: Polypeptides are disclosed herein, which recognize and are strong binders to Influenza A hemagglutinin and can be used, for example, to treat and/or limit development of an influenza infection.
Type:
Application
Filed:
March 21, 2014
Publication date:
July 24, 2014
Applicant:
University of Washington through its Center for Commercialization
Inventors:
David BAKER, Timothy A. WHITEHEAD, Sarel FLEISHMAN
Abstract: Various aspects of the present disclosure are directed toward apparatus, methods, and articles of manufacture for simulating a physical phenomenon characterized by a set of partial differential equations that are reduced based on harmonic time dependence. The system of linear equations represent an operation in the differential equations, and are characterized by a coefficient matrix multiplied by an unknown column vector, with the product thereof being equal to a column vector. The system of linear equations is solved using at least one of three sets of operations.
Type:
Application
Filed:
January 18, 2013
Publication date:
July 24, 2014
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventor:
The Board of Trustees of the Leland Stanford Junior University
Abstract: Disclosed herein are novel compounds of formula (I), and uses thereof. The compounds of Formula (I) are inhibitors of histone deacetylases (HDACs) and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGR). Also provided are methods of using the compounds of Formula (I) for inhibiting the activity of HDACs and HMGR, treating diseases associated with HDACs or HMGR (e.g.
Type:
Application
Filed:
January 21, 2014
Publication date:
July 24, 2014
Applicants:
National Taiwan University, Academia Sinica
Abstract: Methods and compositions are provided for reducing or eliminating charge buildup during scanning electron microscopy (SEM) metrology of a critical dimension (CD) in a structure produced by lithography. An under layer is utilized that comprises silicon in the construction of the structure. When the lithography structure comprising the silicon-comprising under layer is scanned for CDs using SEM, the under layer reduces or eliminates charge buildup during SEM metrological observations.
Type:
Application
Filed:
January 17, 2014
Publication date:
July 24, 2014
Applicants:
Sematech, Inc., The Research Foundation for the State University of New York
Inventors:
MELVIN WARREN MONTGOMERY, Cecilia Annette Montgomery, Benjamin D. Bunday
Abstract: Blood flow rates can be calculated using diffuse speckle contrast analysis in spatial and time domains. In the spatial domain analysis, a multi-pixel image sensor can be used to detect a spatial distribution of speckles in a sample caused by diffusion of light from a coherent light source that is blurred due to the movement of scatterers within the sample (e.g., red blood cells moving within a tissue sample). Statistical analysis of the spatial distribution can be used to calculate blood flow. In the time domain analysis, a slow counter can be used to obtain time-series fluctuations in light intensity in a sample caused by diffusion of light in the sample that is smoothened due to the movement of scatterers. Statistical analysis of the time-series data can be used to calculate blood flow.
Abstract: Described is a method of controlling the absorption of light in a cavity, a system in which absorption is so controlled, and an interferometer embodying the underlying physical concept. Materials can be made to completely absorb incident light when the light is imposed in a specific pattern of illumination. Coherent perfect absorption, as the process is referred to, is achieved when a cavity is illuminated coherently and monochromatically by the time-reverse of the output of a lasing mode. Varying the parameters of the incident light and/or of the cavity allows the absorption of the incident light by the cavity to be controlled; enhanced or even reduced.
Type:
Application
Filed:
March 25, 2014
Publication date:
July 24, 2014
Applicant:
Yale University
Inventors:
A. Douglas Stone, Hui Cao, Li Ge, Yidong Chong
Abstract: Peptide nucleic acids containing thymidine and 2-aminopyridine (M) nucleobases formed stable and sequence selective triple helices with double stranded RNA at physiologically relevant conditions. The M-modified PNA displayed unique RNA selectivity by having two orders of magnitude higher affinity for the double stranded RNAs than for the same DNA sequences. Preliminary results suggested that nucleobase-modified PNA could bind and recognize double helical precursors of microRNAs.
Type:
Application
Filed:
October 29, 2013
Publication date:
July 24, 2014
Applicant:
The Research Foundation for The State University of New York
Abstract: The present invention includes methods for effecting phenotype conversion in a cell by transfecting the cell with phenotype-converting nucleic acid. Expression of the nucleic acids results in a phenotype conversion in the transfected cell. Preferably the phenotype-converting nucleic acid is a transcriptome, and more preferably an mRNA transcriptome.
Type:
Application
Filed:
March 31, 2014
Publication date:
July 24, 2014
Applicant:
The Trustees of the University of Pennsylvania
Inventors:
James Eberwine, Jai-Yoon Sul, Chia-Wen Wu, Fanyi Zeng, Junhyong Kim
Abstract: The present invention provides a system for engaging a fluid flow. The system comprising one or more foil members operationally connected to a feedback control loop system. In one embodiment, the foil member is a hydrofoil member or an airfoil member. The foil members are configured for one or more degrees of freedom of oscillatory movement within the fluid flow. The feedback control loop system comprises a sensor system, actuator system, and a controller system. The feedback control loop system configured for actuating the foil members and thereby optimizing the operation of the foil members to attain one or more optimization objectives. In operation, the foil members are situated in the fluid flow and are manipulated to attain one or more optimization objectives.
Type:
Application
Filed:
January 21, 2014
Publication date:
July 24, 2014
Applicant:
Brown University
Inventors:
Shreyas Mandre, Kenneth Breuer, Benjamin Strom, Michael Miller, Jennifer Franck, Daegyoum Kim
Abstract: The present invention provides a quantitative, automated system and method for assessing the correlation level of two rendered images, thereby removing subjectivity from such evaluation. The objective metric of the present invention determines whether two static images are correlated enough to be undetectable by a human observer. The performance of this method is optimized based upon the capabilities and limitations of the human visual system. Therefore, the resulting assessments are not overly sensitive and reduce the resources required to assess rendered images within a networked simulation environment. Additionally, the simplicity of the method lends itself to implementation within existing and emerging simulation systems with relatively little effort compared to current assessment methods. The system and method of the present invention provide benefits to multiple organizations, such as those engaged in human-in-the-loop simulators, distributed learning, and training applications.
Type:
Application
Filed:
January 22, 2014
Publication date:
July 24, 2014
Applicant:
University of Central Florida Research Foundation, Inc.
Inventors:
Stephanie Lackey, Joseph Fanfarelli, Eric Ortiz, Daniel Barber
Abstract: A method for the treatment of solvent-containing MOF material to increase its internal surface area involves introducing a liquid into the MOF in which liquid the solvent is miscible, subjecting the MOF to supercritical conditions for a time to form supercritical fluid, and releasing the supercritical conditions to remove the supercritcal fluid from the MOF. Prior to introducing the liquid into the MOF, occluded reaction solvent, such as DEF or DMF, in the MOF can be exchanged for the miscible solvent.